On the Path to 2025: Treatments and Diagnostics to Change the Trajectory of the Disease
What are the latest innovations in the drug pipeline? How important is the need to develop diagnostics that can improve diagnosis and draw more patients into clinical trials, especially patients at high risk of Alzheimer’s? The panel will underscore the critical importance of progress on detection, diagnosis, research and treatments to stop Alzheimer’s. Key question: Will the U.S. meet our national goal of preventing and effectively treating Alzheimer's disease by 2025?